...in a series A round led by Versant Ventures...

...part of what the company is working on.Of syndicates and SoftbankThe series C round saw Versant Ventures...
...Logos Capital, which co-led the deal with fellow new investor Boxer Capital of Tavistock Group. Versant...

...in an IPO through the sale of 8 million shares at $13.$80M series C for Versant-grown...
...Suvretta Capital and Red Tree Venture Capital. All the company’s existing shareholders, including founding investor Versant Ventures...

...biotechs, and VC firms 5AM Ventures and Versant Ventures...

...start-ups, including cell therapy company Lyell Immunopharma Inc., Versant-backed...

...Alexandria Venture Investments and others, including series A investors venBio Partners, Versant Ventures and Samsara Bio Capital.Versant’s...
...Jerel Davis said the firm scouted radiotherapy opportunities for three years before investing in RayzeBio Inc. Versant...

...milestones. He was also a partner at Versant Ventures...

...at Versant Ventures and CEO of Blueline Bioscience, Versant’s...

...A round co-led by venBio Partners and Versant Ventures...
...have not yet been addressed with radiopharmaceuticals. Versant’s...
...employees: 10Funds raised: $45 millionInvestors: venBio Partners, Versant Ventures...

...a £29 million ($40.9 million) series B round in 2018. Investors included Epidarex Capital, IP Group, Versant Ventures...